Management of Staphylococcus Species Bacteremia
Initial Steps
- The Infectious Diseases Society of America recommends obtaining at least two sets of blood cultures before initiating antimicrobial therapy to confirm true bacteremia and rule out contamination 2, 1
- Immediate initiation of empiric vancomycin therapy is recommended while awaiting final identification and susceptibility testing, with catheter removal indicated for Staphylococcus aureus bacteremia 1
- Rapid molecular testing (PCR) can quickly identify Staphylococcus species and determine methicillin susceptibility, reducing time to targeted therapy by approximately 39 hours compared to conventional methods 3, 4
- Source control measures, particularly evaluation for removal of intravascular catheters, should be considered 5, 2
Management Based on Staphylococcus Species Identification
- For Staphylococcus aureus bacteremia, removal of all intravascular catheters is strongly recommended (Level A-II evidence) 5, 2
- Echocardiography should be performed to rule out endocarditis, particularly in patients with persistent bacteremia 2
- Additional blood cultures should be obtained at 48-72 hours to document clearance of bacteremia 2, 1
- Appropriate antibiotic therapy should be continued based on susceptibility results, with options including anti-staphylococcal beta-lactams for methicillin-susceptible S. aureus (MSSA) and vancomycin for methicillin-resistant S. aureus (MRSA) 1
Duration of Therapy
- For uncomplicated S. aureus bacteremia, 2 weeks of appropriate antibiotic therapy is recommended 1
- For complicated S. aureus bacteremia, 4-6 weeks of therapy is recommended 2, 1
- For CoNS bacteremia with catheter removal, 5-7 days of appropriate antibiotic therapy is recommended 2
- For CoNS bacteremia with catheter retention, 10-14 days of systemic therapy plus antimicrobial lock therapy is recommended 2
Antibiotic Options
- First-line empiric therapy is vancomycin 15-20 mg/kg IV every 8-12 hours (adjusted for renal function) 1
- Alternative options for patients who cannot tolerate vancomycin include linezolid and daptomycin 1
Monitoring and Follow-up
- Vancomycin trough levels should be monitored, with a target of 15-20 mg/L for serious S. aureus infections 1
- Daily blood cultures should be performed until documented clearance of bacteremia 1
- Patients with S. aureus bacteremia who have persistent positive blood cultures after 72 hours of appropriate therapy should be evaluated for endocarditis, metastatic foci of infection, infected devices requiring removal, and development of resistance 5, 2, 1
Common Pitfalls and Caveats
- Failure to remove infected catheters, particularly with S. aureus bacteremia, is associated with treatment failure and increased mortality 5, 2
- Treating all CoNS-positive blood cultures as true infections can lead to unnecessary antibiotic use; clinical correlation and multiple cultures are essential 2
- Delayed switch from vancomycin to beta-lactam antibiotics for MSSA bacteremia is associated with poorer outcomes; rapid PCR testing can reduce this delay 3, 4
- Failure to perform follow-up blood cultures to document clearance of bacteremia may miss persistent infections requiring extended therapy 2